Caribou Biosciences (CRBU) Receivables - Net (2020 - 2026)
Caribou Biosciences (CRBU) reported Receivables - Net of $227000.0 for Q1 2026, up 157.95% year-over-year from $88000.0 in Q1 2025, and up 228.99% on a QoQ basis from $69000.0 in Q4 2025.
Caribou Biosciences (CRBU) has 7 years of Receivables - Net data on file, last reported at $227000.0 in Q1 2026.
- Quarterly Receivables - Net rose 157.95% year-over-year to $227000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $227000.0 (up 157.95% YoY) and the FY2025 annual result came in at $69000.0, down 73.96% from the prior year.
- Receivables - Net grew to $227000.0 in Q1 2026 per CRBU's latest filing, from $69000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $1.5 million in Q1 2023 and bottomed at $69000.0 in Q4 2025.
- The 5-year median for Receivables - Net is $242000.0 (2025), against an average of $432647.1.
- The widest annual swing landed in 2022, when Receivables - Net soared 26100.0%; it then plunged 90.4% in 2025.
- Tracing CRBU's Receivables - Net over 5 years: stood at $202000.0 in 2022, then retreated by 26.73% to $148000.0 in 2023, then jumped by 79.05% to $265000.0 in 2024, then plunged by 73.96% to $69000.0 in 2025, then soared by 228.99% to $227000.0 in 2026.
- Per Business Quant, the three latest CRBU Receivables - Net figures stand at $227000.0 (Q1 2026), $69000.0 (Q4 2025), and $242000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227,000.00 |
| Mar 31, 2026 | 227,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 265,000.00 |
| Dec 31, 2024 | 265,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 215,000.00 |
| Jun 30, 2024 | 215,000.00 |
| Mar 31, 2024 | 917,000.00 |
| Mar 31, 2024 | 917,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Dec 31, 2023 | 148,000.00 |
| Sep 30, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 766,000.00 |
| Mar 31, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 202,000.00 |
| Dec 31, 2022 | 202,000.00 |
| Sep 30, 2022 | 397,000.00 |
| Sep 30, 2022 | 397,000.00 |
| Jun 30, 2022 | 524,000.00 |
| Jun 30, 2022 | 524,000.00 |
| Mar 31, 2022 | 374,000.00 |
| Mar 31, 2022 | 374,000.00 |
| Dec 31, 2021 | 1.15 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 578,000.00 |
| Sep 30, 2021 | 578,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Dec 31, 2020 | 150,000.00 |
| Dec 31, 2020 | 150,000.00 |